These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
287 related articles for article (PubMed ID: 15453119)
1. [Long acting insulin analogs: possibly more stable glucose regulation]. Huvers F Ned Tijdschr Geneeskd; 2004 Aug; 148(34):1674-8. PubMed ID: 15453119 [TBL] [Abstract][Full Text] [Related]
2. Negative binomial meta-regression analysis of combined glycosylated hemoglobin and hypoglycemia outcomes across eleven Phase III and IV studies of insulin glargine compared with neutral protamine Hagedorn insulin in type 1 and type 2 diabetes mellitus. Mullins P; Sharplin P; Yki-Jarvinen H; Riddle MC; Haring HU Clin Ther; 2007 Aug; 29(8):1607-19. PubMed ID: 17919543 [TBL] [Abstract][Full Text] [Related]
3. The use of insulin analogues in pregnancy. Lambert K; Holt RI Diabetes Obes Metab; 2013 Oct; 15(10):888-900. PubMed ID: 23489521 [TBL] [Abstract][Full Text] [Related]
4. Is insulin detemir able to favor a lower variability in the action of injected insulin in diabetic subjects? Valensi P; Cosson E Diabetes Metab; 2005 Sep; 31(4 Pt 2):4S34-4S39. PubMed ID: 16389896 [TBL] [Abstract][Full Text] [Related]
6. Insulin detemir improves glycemic control and reduces hypoglycemia in children with type 1 diabetes: findings from the Turkish cohort of the PREDICTIVE observational study. Kurtoglu S; Atabek ME; Dizdarer C; Pirgon O; Isguven P; Emek S; Pediatr Diabetes; 2009 Sep; 10(6):401-7. PubMed ID: 19220776 [TBL] [Abstract][Full Text] [Related]
7. Changing basal insulin from NPH to detemir or glargine in patients with type 1 diabetes and a history of severe hypoglycemia. Johansen OE; Vanberg PJ; Kilhovd BK; Jørgensen AP Vasc Health Risk Manag; 2009; 5(1):121-8. PubMed ID: 19436668 [TBL] [Abstract][Full Text] [Related]
8. Glargine is superior to neutral protamine Hagedorn for improving glycated haemoglobin and fasting blood glucose levels during intensive insulin therapy. Fulcher GR; Gilbert RE; Yue DK Intern Med J; 2005 Sep; 35(9):536-42. PubMed ID: 16105155 [TBL] [Abstract][Full Text] [Related]
9. Insulin detemir lowers the risk of hypoglycaemia and provides more consistent plasma glucose levels compared with NPH insulin in Type 1 diabetes. Kølendorf K; Ross GP; Pavlic-Renar I; Perriello G; Philotheou A; Jendle J; Gall MA; Heller SR Diabet Med; 2006 Jul; 23(7):729-35. PubMed ID: 16842476 [TBL] [Abstract][Full Text] [Related]
10. Differences between long-acting insulins for the treatment of type 2 diabetes. Jensen MG; Hansen M; Brock B; Rungby J Expert Opin Pharmacother; 2010 Aug; 11(12):2027-35. PubMed ID: 20642370 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of conversion from bedtime NPH insulin injection to once- or twice-daily injections of insulin glargine in type 1 diabetic patients using basal/bolus therapy. Albright ES; Desmond R; Bell DS Diabetes Care; 2004 Feb; 27(2):632-3. PubMed ID: 14747268 [No Abstract] [Full Text] [Related]
12. Better long-term glycaemic control with the basal insulin glargine as compared with NPH in patients with Type 1 diabetes mellitus given meal-time lispro insulin. Porcellati F; Rossetti P; Pampanelli S; Fanelli CG; Torlone E; Scionti L; Perriello G; Bolli GB Diabet Med; 2004 Nov; 21(11):1213-20. PubMed ID: 15498088 [TBL] [Abstract][Full Text] [Related]
13. Insulin during pregnancy, labour and delivery. de Valk HW; Visser GH Best Pract Res Clin Obstet Gynaecol; 2011 Feb; 25(1):65-76. PubMed ID: 21186142 [TBL] [Abstract][Full Text] [Related]
14. (Ultra-)long-acting insulin analogues for people with type 1 diabetes mellitus. Hemmingsen B; Metzendorf MI; Richter B Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013498. PubMed ID: 33662147 [TBL] [Abstract][Full Text] [Related]
15. Insulin detemir improves glycaemic control with less hypoglycaemia and no weight gain in patients with type 2 diabetes who were insulin naive or treated with NPH or insulin glargine: clinical practice experience from a German subgroup of the PREDICTIVE study. Meneghini LF; Rosenberg KH; Koenen C; Merilainen MJ; Lüddeke HJ Diabetes Obes Metab; 2007 May; 9(3):418-27. PubMed ID: 17391170 [TBL] [Abstract][Full Text] [Related]
16. Will the use of insulin analogs improve glycemic control during adolescence? Dunger DB Pediatr Diabetes; 2003 Jun; 4(2):61-3. PubMed ID: 14655260 [No Abstract] [Full Text] [Related]
17. Omitting breakfast and lunch after injection of different long-acting insulin preparations at bedtime: a prospective study in patients with type 2 diabetes. Wiesli P; Krayenbühl P; Uthoff H; Seifert B; Schmid C Diabetologia; 2009 Sep; 52(9):1816-9. PubMed ID: 19565212 [TBL] [Abstract][Full Text] [Related]
18. Indirect comparison of once daily insulin detemir and glargine in reducing weight gain and hypoglycaemic episodes when administered in addition to conventional oral anti-diabetic therapy in patients with type-2 diabetes. Fakhoury W; Lockhart I; Kotchie RW; Aagren M; LeReun C Pharmacology; 2008; 82(2):156-63. PubMed ID: 18679040 [TBL] [Abstract][Full Text] [Related]
19. Comparison of fasting capillary glucose variability between insulin glargine and NPH. Mu P; Lu H; Zhang G; Chen Y; Fu J; Wang M; Shu J; Zeng L Diabetes Res Clin Pract; 2011 Jan; 91(1):e4-7. PubMed ID: 20970870 [TBL] [Abstract][Full Text] [Related]
20. Concomitant use of insulin glargine and NPH in type I diabetes. Khadilkar VV; Khadilkar AV Indian Pediatr; 2005 Aug; 42(8):796-800. PubMed ID: 16141481 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]